Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals

By J. Scheid, H. Mouquet, N. Feldhahn, M. Seaman, K. Velinzon, J. Pietzsch, R. G. Ott, R. Anthony, H. Zebroski, A. Hurley and 12 more. Nature, 2009

900 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals (2020, background): “(8) Association Ab2: sensors immersed 5 min with Ab2 at 40 μg/mL.”
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells (2020, positive): “The method has led to efﬁcient isolation of neutralizing mAbs in various infectious diseases, including HIV and MERS (Scheid et al., 2009; Wang et al., 2018).”
From Vaccines to Memory and Back (2010, positive): “…followed by selection with functional assays (Traggiai et al., 2004), or by isolation of antigen-binding memory B cells or of total plasma cells followed by rescue of the specific antibodies by single cell PCR and expression in heterologous systems (Scheid et al., 2009; Wrammert et al., 2008).”